Azione 002198 GUANGDONG JIAYING PHARMACEUTICAL CO., LTD
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Guangdong Jiaying Pharmaceutical Co., Ltd

Azioni

002198

CNE1000008P1

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 15/07/2024 		Variaz. 5gg Var. 1 gen.
6,69 CNY +0,90% Grafico intraday di Guangdong Jiaying Pharmaceutical Co., Ltd -12,20% -8,10%
08/07 Huang Junjie ha completato l'acquisizione della partecipazione del 5,03% in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) da Liu Libiao. CI
08/07 Huang Junjie ha completato l'acquisizione della partecipazione del 5,03% in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) da Liu Libiao. CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Yangtianhe Pharmacy Co., Ltd. signed Share Transfer Agreement to acquire 7% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 360 million.
Huang Junjie completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao.
Huang Junjie completed the acquisition of 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao.
Huang Junjie signed share transfer agreement to acquire 5.03% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Liu Libiao for CNY 230 million.
Guangdong Jiaying Pharmaceutical Co., Ltd Approves Final Cash Dividend for the Year 2023 on A Shares, Payable on 21 June 2024
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Announcement of Resolutions of Guangdong Jiaying?s Fifth Extraordinary General Meeting of Shareholders in 2021
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd. Approves Management Appointments
Resolutions on Supervisor Nomination by Guangdong Jiaying Venture Capital
Guangdong Jiaying Venture Capital Submits Proposals Related to Supervisor Nominations
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Guangzhou Taiping Enterprise Management Partnership (Limited Partnership) signed the Share Transfer Agreement to acquire 5% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 195 million.
Jiaying Pharma Sees Up to 3,420% Surge in 2022 Profit
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Guangdong Jiaying Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 002198
  4. Notizie Guangdong Jiaying Pharmaceutical Co., Ltd
  5. Altre lingue